Recent studies (see Table 2 for a summary) provide evidence for NRG4’s potential cardioprotective properties, indicating its crucial role in mitigating the adverse impacts of obesity, insulin resistance, and metabolic dysfunction on heart health [47]. This evidence concerns the gene NRG4 and obesity due to melanocortin 4 receptor deficiency.